Skip to main content

Advertisement

Table 2 Changes in liver functions of liver cirrhotic patients with TIPS treatment

From: Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment

  Baseline 1 year 2 years 3 years 4 years 5 years
(n = 704) (n = 638) (n = 587) (n = 530) (n = 485) (n = 445)
ALT (U/L) 51 ± 28 47 ± 19 55 ± 31 52 ± 21 58 ± 20 55 ± 18
T-BIL (μmol/L) 29.2 ± 19.7 34.8 ± 20.1 32.9 ± 21.8 35.9 ± 20.8 34.6 ± 19.7 27.6 ± 18.0
Albumin (g/L) 28.9 ± 10.2 29.1 ± 11.7 30.0 ± 9.8 28.7 ± 8.2 29.7 ± 9.2 30.1 ± 12.8
Blood ammonia (μmol/L) 64.7 ± 25.9 87.6 ± 27.1 ## 81.5 ± 19.8 ## 76.2 ± 20.5 ## 78.2 ± 21.2 # 71.0 ± 11.6
PTA (%) 56.8 ± 12.5 37.8 ± 9.1 # 51.4 ± 8.7 49.2 ± 11.0 50.1 ± 10.2 50.8 ± 8.9
INR 1.36 ± 0.23 1.90 ± 0.46 # 1.48 ± 0.51 1.50 ± 0.49 1.50 ± 0.44 1.47 ± 0.38
Stiffness (KPa) 18.6 ± 10.7 17.6 ± 9.8 17.9 ± 12.7 16.8 ± 8.6 16.7 ± 9.1 17.1 ± 10.2
  1. #P < 0.05, ## P < 0.01 compared with baseline, Dunn’s multiple comparison test